Eva Balslev

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Ann Knoop, Helle Knudsen, Eva Balslev et al. · Journal of Clinical Oncology · 2005 · 323 citations · Full text

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim et al. · npj Breast Cancer · 2020 · 190 citations · Full text

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

Inge Marie Svane, Anders Elm Pedersen, Julia S. Johansen et al. · Cancer Immunology Immunotherapy · 2007 · 102 citations · Full text

Vaccination, Cancer Immunosurveillance, Breast Oncology +12

Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial

Mogens Bernsdorf, Christian Ingvar, Leif Jørgensen et al. · Breast Cancer Research and Treatment · 2011 · 79 citations · Full text

Breast Oncology, Oncology, Medicine +7

High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer

Lene Rask, Eva Balslev, Stine Jørgensen et al. · Apmis · 2011 · 78 citations

Breast Oncology, Pathology, Human Breast Cancer +17